205 related articles for article (PubMed ID: 8667051)
1. Technetium-99m-MIBI scintigraphy in pulmonary tuberculosis.
Onsel C; Sönmezoglu K; Camsari G; Atay S; Cetin S; Erdil YT; Uslu I; Uzun A; Kanmaz B; Sayman HB
J Nucl Med; 1996 Feb; 37(2):233-8. PubMed ID: 8667051
[TBL] [Abstract][Full Text] [Related]
2. Technetium-99m-tetrofosmin scintigraphy in pulmonary tuberculosis.
Degirmenci B; Kilinc O; Cirak KA; Capa G; Akpinar O; Halilcolar H; Durak H; Akkoclu A; Derebek E; Ucan ES
J Nucl Med; 1998 Dec; 39(12):2116-20. PubMed ID: 9867153
[TBL] [Abstract][Full Text] [Related]
3. 99mTc-hexakis methoxy isobutyl isonitrile MIBI scintigraphy and bronchoalveolar fluid lactic dehydrogenase in pulmonary tuberculosis.
Alavi M; Emad AF; Bahtouee M
Hell J Nucl Med; 2008; 11(2):110-3. PubMed ID: 18815666
[TBL] [Abstract][Full Text] [Related]
4. 99mTc isonitrils biophysical aspects in pulmonary tuberculosis. Part I. In vivo evaluation of 99mTc MIBI and 99mTc Tetrofosmin biophysical localization mechanisms.
Stefanescu C; Rusu V; Boişteanu D; Azoicai D; Costin M; Oleniuc D; Hurjui M; Sattish P
Rev Med Chir Soc Med Nat Iasi; 2006; 110(4):944-9. PubMed ID: 17438905
[TBL] [Abstract][Full Text] [Related]
5. The role of 99mTc-MIBI scintigraphy in the management of patients with pulmonary tuberculosis.
Raziei G; Masjedi MR; Fotouhi F; Asli NI; Shafiei B; Javadi H; Assadi M
Eur Rev Med Pharmacol Sci; 2012 May; 16(5):622-9. PubMed ID: 22774403
[TBL] [Abstract][Full Text] [Related]
6. Application of technetium-99m-sestamibi in differentiation of active from inactive pulmonary tuberculosis using a single photon emission computed tomography method.
Ahmadihosseini H; Sadeghi R; Zakavi R; Kakhki VR; Kakhki AH
Nucl Med Commun; 2008 Aug; 29(8):690-4. PubMed ID: 18753821
[TBL] [Abstract][Full Text] [Related]
7. Multiple myeloma: predictive value of Tc-99m MIBI scintigraphy and MRI in its diagnosis and therapy.
Myslivecek M; Nekula J; Bacovsky J; Scudla V; Koranda P; Kaminek M
Nucl Med Rev Cent East Eur; 2008; 11(1):12-6. PubMed ID: 19173182
[TBL] [Abstract][Full Text] [Related]
8. Clinical diagnostic value of simultaneous amplification and testing for the diagnosis of sputum-scarce pulmonary tuberculosis.
Yan L; Zhang Q; Xiao H
BMC Infect Dis; 2017 Aug; 17(1):545. PubMed ID: 28779754
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of technetium-99m sestamibi in patients with multiple myeloma and potential role in the follow-up.
Pace L; Catalano L; Del Vecchio S; Di Gennaro F; De Renzo A; Sica G; Califano C; Tedesco N; Borrelli G; Rotoli B; Salvatore M
Eur J Nucl Med; 2001 Mar; 28(3):304-12. PubMed ID: 11315597
[TBL] [Abstract][Full Text] [Related]
10. 99mTc-MIBI scintigraphy in untreated stage III multiple myeloma: comparison with X-ray skeletal survey and bone scintigraphy.
Alper E; Gurel M; Evrensel T; Ozkocaman V; Akbunar T; Demiray M
Nucl Med Commun; 2003 May; 24(5):537-42. PubMed ID: 12717071
[TBL] [Abstract][Full Text] [Related]
11. 99mTc-MIBI scintigraphy for early detection of locally recurrent non-small cell lung cancer treated with definitive radiation therapy.
Furuta M; Nozaki M; Kawashima M; Iimuro M; Kitazumi Y; Okayama A; Natsui S; Hamashima Y; Nagao K
Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):982-7. PubMed ID: 12734691
[TBL] [Abstract][Full Text] [Related]
12. Different patterns of technetium-99m sestamibi uptake in multiple myeloma.
Pace L; Catalano L; Pinto A; De Renzo A; Di Gennaro F; Califano C; Del Vecchio S; Rotoli B; Salvatore M
Eur J Nucl Med; 1998 Jul; 25(7):714-20. PubMed ID: 9662593
[TBL] [Abstract][Full Text] [Related]
13. Laboratory diagnosis of pulmonary tuberculosis in TB and HIV endemic settings and the contribution of real time PCR for M. tuberculosis in bronchoalveolar lavage fluid.
Kibiki GS; Mulder B; van der Ven AJ; Sam N; Boeree MJ; van der Zanden A; Dolmans WM
Trop Med Int Health; 2007 Oct; 12(10):1210-7. PubMed ID: 17956503
[TBL] [Abstract][Full Text] [Related]
14. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Tsuchiya H; Tomita K; Nonomura A; Tonami N
J Nucl Med; 1997 Apr; 38(4):501-6. PubMed ID: 9098190
[TBL] [Abstract][Full Text] [Related]
15. Staging and therapy monitoring of multiple myeloma by 99mTc-sestamibi scintigraphy: a five year single center experience.
Villa G; Balleari E; Carletto M; Grosso M; Clavio M; Piccardo A; Rebella L; Tommasi L; Morbelli S; Peschiera F; Gobbi M; Ghio R
J Exp Clin Cancer Res; 2005 Sep; 24(3):355-61. PubMed ID: 16270521
[TBL] [Abstract][Full Text] [Related]
16. 99mTc-MIBI Lung Scintigraphy in the Assessment of Pulmonary Involvement in Interstitial Lung Disease and Its Comparison With Pulmonary Function Tests and High-Resolution Computed Tomography: A Preliminary Study.
Bahtouee M; Saberifard J; Javadi H; Nabipour I; Raeisi A; Assadi M; Eftekhari M
Medicine (Baltimore); 2015 Nov; 94(47):e2082. PubMed ID: 26632717
[TBL] [Abstract][Full Text] [Related]
17. Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scans.
Mele A; Offidani M; Visani G; Marconi M; Cambioli F; Nonni M; Catarini M; Brianzoni E; Berbellini A; Ascoli G; Brunori M; Agostini V; Corvatta L; Isidori A; Spinelli A; Gradari M; Leoni P
Br J Haematol; 2007 Mar; 136(5):729-35. PubMed ID: 17233770
[TBL] [Abstract][Full Text] [Related]
18. 99mTc isonitrils biophysical aspects in pulmonary tuberculosis. Part II. In vitro evaluation of 99mTc MIBI cellular uptake mechanism.
Stefănescu C; Rusu V; Azoicăi D; Hurjui I
Rev Med Chir Soc Med Nat Iasi; 2007; 111(1):210-5. PubMed ID: 17595869
[TBL] [Abstract][Full Text] [Related]
19. Assessment of 99mTc-MIBI SPECT(/CT) to monitor multidrug resistance-related proteins and apoptosis-related proteins in patients with ovarian cancer: a preliminary study.
Kurata S; Ushijima K; Kawahara A; Kaida H; Kawano K; Hirose Y; Kage M; Kamura T; Ishibashi M; Abe T
Ann Nucl Med; 2015 Aug; 29(7):643-9. PubMed ID: 25921216
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
